The integrase (IN) enzyme represents an important chemotherapeutic target as its inhibition blocks infection by human immunodeficiency virus type 1 (HIV-1), which is responsible for acquired immune deficiency syndrome (AIDS). This evidence concerns the gene CD44 and AIDS.